Biotech Challenges

2005 could be a key year for a number of Washington area biotechnology companies, including:


Advancis Pharmaceutical Corp.
Headquarters: Germantown
Revenue: $3.6 million
Loss: $21 million
Employees: 87
Key in 2005: Get successful results from final testing of a slow-release antibiotic before money runs out.

MedImmune Inc.
Headquarters: Gaithersburg
Revenue: $1.1 billion
Profit: $183 million
Employees: about 2,000
Key in 2005: Get successful test results for an improved version of FluMist inhaled vaccine.

Human Genome Sciences Inc.
Headquarters: Rockville
Revenue: $8.1 million
Loss: $185 million
Employees: about 900
Key in 2005: Move several drugs toward final human tests.

GenVec Inc.
Headquarters: Gaithersburg
Revenue: $10.5 million
Net loss: $21.2 million
Employees: about 100
Key in 2005: Persuade FDA to lift hold on testing of its lead product, a cancer therapy.

Digene Corp.
Headquarters: Gaithersburg
Revenue: $90.2 million
Net income: $21.5 million
Employees: about 400
Key in 2005: Before a competitor enters the market, increase sales of a test to detect a virus that leads to cervical cancer.

Note: Revenue and earnings figures from 2003

COMPILED BY MICHAEL ROSENWALD - THE WASHINGTON POST


© 2004 The Washington Post Company